Can NK cells play a role in anti-CD20 immunotherapy for CLL patients?

被引：0
|
作者：
Le Garff-Tavemier, Magali [1 ]
De Romeuf, Christophe [2 ]
Teillaud, Jean-Luc [3 ]
Decocq, Julie [2 ]
Dutertre, Charles-Antoine [3 ]
Debre, Patrice [1 ]
Merle-Beral, Helene [1 ]
Vieillard, Vincent [1 ]
机构：
[1] Hop La Pitie Salpetriere, INSERM, U543, Paris, France
[2] Lab Francais Fractionnement & Biotechnol, Les Ulis, France
[3] Ctr Rech Biomed Cordeliers, Paris, France
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3103.3103
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3103
引用
收藏
页码：913A / 913A
页数：1
相关论文
共 50 条
  • [31] B-cells transcriptome analysis in pemphigus patients after anti-CD20 treatment
    Caillot, F.
    Derambure, C.
    Berkani, N.
    Riou, G.
    Vaillant, M. Maho
    Calbo, S.
    Joly, P.
    Musette, P.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S222 - S222
  • [32] The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders
    Musto, Pellegrino
    D'Auria, Fiorella
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (05) : 551 - 557
  • [33] A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
    Capolla, Sara
    Mezzaroba, Nelly
    Zorzet, Sonia
    Tripodo, Claudio
    Mendoza-Maldonado, Ramiro
    Granzotto, Marilena
    Vita, Francesca
    Spretz, Ruben
    Larsen, Gustavo
    Noriega, Sandra
    Mansilla, Eduardo
    Dal Bo, Michele
    Gattei, Valter
    Pozzato, Gabriele
    Nunez, Luis
    Macor, Paolo
    [J]. NANO RESEARCH, 2016, 9 (02) : 537 - 548
  • [34] A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL
    Mato, Anthony R.
    Roeker, Lindsey E.
    Eyre, Toby A.
    Nabhan, Chadi
    Lamanna, Nicole
    Hill, Brian T.
    Brander, Danielle M.
    Barr, Paul M.
    Lansigan, Frederick
    Cheson, Bruce D.
    Singavi, Arun K.
    Yazdy, Maryam Sarraf
    Shah, Nirav N.
    Allan, John N.
    Bhavsar, Erica B.
    Rhodes, Joanna
    Kennard, Kaitlin
    Schuster, Stephen J.
    Williams, AnnaLynn M.
    Skarbnik, Alan P.
    Goy, Andre H.
    Goodfriend, Julie M.
    Dorsey, Colleen
    Coombs, Catherine C.
    Tuncer, Hande
    Ujjani, Chaitra S.
    Jacobs, Ryan
    Winter, Allison M.
    Pagel, John M.
    Bailey, Neil
    Schuh, Anna
    Shadman, Mazyar
    Sitlinger, Andrea
    Weissbrot, Hanna
    Muralikrishnan, Sivraj
    Zelenetz, Andrew
    Kirkwood, Amy A.
    Fox, Christopher P.
    [J]. BLOOD ADVANCES, 2019, 3 (10) : 1568 - 1573
  • [35] A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
    Sara Capolla
    Nelly Mezzaroba
    Sonia Zorzet
    Claudio Tripodo
    Ramiro Mendoza-Maldonado
    Marilena Granzotto
    Francesca Vita
    Ruben Spretz
    Gustavo Larsen
    Sandra Noriega
    Eduardo Mansilla
    Michele Dal Bo
    Valter Gattei
    Gabriele Pozzato
    Luis Núñez
    Paolo Macor
    [J]. Nano Research, 2016, 9 : 537 - 548
  • [36] HDAC6 Inhibition Increases Translation of CD20 mRNA and Potentiates the Efficacy of Anti-CD20 Immunotherapy
    Bobrowicz, Malgorzata
    Stachura, Joanna
    Dwojak, Michal
    Domagala, Antoni
    Pyrzynska, Beata
    Berthel, Elise
    Venezia, Nicole Dalla
    Siernicka, Marta
    Firczuk, Malgorzata
    Winiarska, Magdalena
    [J]. BLOOD, 2016, 128 (22)
  • [37] Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis
    Thaunat, Olivier
    Morelon, Emmanuel
    Defrance, Thierry
    [J]. BLOOD, 2010, 116 (04) : 515 - 521
  • [38] HBV Care Map for Patients Receiving Anti-CD20 Therapy
    Liederman, Zachary
    Berinstein, Neil
    Crump, Michael
    Hwang, Jessica
    Janssen, Harry L. A.
    Kouroukis, C. Tom
    Leung, Patricia
    Lok, Anna
    Yim, Colina
    Zelenetz, Andrew D.
    Chan, Kelvin
    Feld, Jordan
    Hicks, Lisa K.
    [J]. BLOOD, 2017, 130
  • [39] Intravenous infusion of activated autologous macrophages armed with anti-CD20 monoclonal antibodies can yield sustained molecular remission in CLL.
    Sutton, L
    Azar, N
    Cazin, B
    Baudet, S
    Reynes, N
    Tardy, D
    Abastado, JP
    Romet-Lemonne, JL
    Maloum, K
    [J]. BLOOD, 2001, 98 (11) : 808A - 808A
  • [40] Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (Rituximab).
    Musette, P
    Mouquet, H
    Jacquot, S
    Gilbert, D
    Huetz, F
    Roujeau, JC
    D'Incan, M
    Doutre, MS
    Gorin, I
    Caux, F
    Bedane, C
    Oro, S
    Tron, F
    Joly, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (06) : A16 - A16
12345